Member Info for Dosanddonts

We have 2month left from the 6month specified for 9 more countries to come online! That’s a busy Jan/Feb! To me this points to the fact someone’s not pulling their weight or a mass release? I hope it’s the latter.

BOD benefits from low SP last 10 days of trading year as they are allocated shares at the average 10 day price this year for 2025 remuneration share award. Part of their bumper pay packet is made up of shares! So will only release what news they are forced to! But I expect big news in the new year

Pj- when you release poor RNS’s like the BOD do and decide not to release financials when it would be beneficial to the SP. Then yes the BOD control the SP to a degree! As I’ve said low SP is beneficial to them, post Jan we will see things looking up as BOD will have gettin what they wanted cheap shares next year!

Would like to think we would get an update on sales in UK,EU & Saudi, think FUM are keeping share price artificially low! As I’ve said before BOD get there allocated shared last 10 days of trading so we will be into next year now.

Melanzane- Rolling out to 10 countries not sure what you are saying?

18th Sep 2023 RNS

Over the next six months or so, our distributors will look to move into the next phase of its rollout and launch of Eroxon® with at least a further ten new country launches.

Good news ahead 3month & we have seen 1 Saudi, so the other nine by 18th March 2024, not convinced but we will see! Be patient people say, well my patience is wearing thin, hope they keep to the only plan they have shared!

IMO I’m convinced £90p is coming but not sure by what means. At a market cap of £90mil, surely some of the big players are wondering whether a buy out would make sense with £200mill a year solely for the US. I reckon £1.20 a share would do it!

Toli- what RNS are you expecting? Recent RNS’s have done nothing but destroy the SP & as BOD get shares allocated based on the last 10 days trading average in Dec price I don’t fancy there’s much chance of them releasing anything unless their forced into it?

Why do the BOD still refuse to release informative RNS’s even after being called out on them? For one would not hurt to mention the market size in the regions acquired? The market size by value in the regions. At least then investor could estimate value to FUM. NOTHING AGAIN, clearly can’t teach an old dog new tricks! Get Rid of whoever is drafting these RNS’s fast.

Love sushi-what was the downside for the drop? Until financials are out to back this up with repeat sales we will be up & down new and all!

I would now like to see the BOD capitalise off this with maybe some advertising stating product of the year, website stating product of the year, maybe even packaging which I know can sometimes be difficult. Let’s see but I think not because wrong people for the job! This could be massive news but just watch will go unnoticed as BOD don’t have a clue! Harsh but I feel true.

Always a dip before Xmas apart from 2022, they must of f’d up! I know I’m prob not helping here but very annoyed with the BOD!

Maybe Barder & the cronies are the problem, the lower it goes the better for them! Or maybe I’m just paranoid??

“Directors receive 25-30 per cent of their remuneration in the form of Ordinary Shares. For 2022, these were issued at 36.36 pence per share, being the average closing mid-market price of the last 10 trading days of 2021 (as announced via RNS on 13 January 2022).”

Nhamid- I don’t agree people wouldn’t buy to try Eroxon based on the reviews as the reviews state it either works or doesn’t! Which will always be the case with a medical product and worth a try as no side effects. As for US this will be the only over the counter ED product so much cheaper than paying for a medical consultation & the medication! So worth a try regardless. Issue is repeat buying & if the 60% it worked for in the trials works in the real world! There was a trial done by Cooper who validated this, but worldwide who knows thats the gamble IMO.

I would recommend as others on here have said to contact FUM via email on the website under contacts to stress your grievances! We need answers! I for one have done so, it started very diplomatic but frustration got the better of me so I don’t expect a reply.😂

Not a laughing matter I know but it either that or cry!

Looks like BOD are releasing another RNS in the morning! I’m hoping for a day with no RNS releases to steady the ship.😂

Thing is this isn’t Barders first Rodeo with getting a product to market & his incompetence!

FairyG-I agree BOD are useless & it’s as simple as that! Good example of how to destroy an otherwise great product with incompetence!

Long term potential hasn’t changed, very good with potential £1bill revenue on the cards. Do the BOD have shares taken off them for poor SP performance guessing not!!!! But how can they reward themselves on what we are seeing currently & Yes it is partly their fault!